293 related articles for article (PubMed ID: 30549197)
1. Review of rodent hypertensive glaucoma models.
Biswas S; Wan KH
Acta Ophthalmol; 2019 May; 97(3):e331-e340. PubMed ID: 30549197
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the endothelin A (ET
McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
4. Rodent models of glaucoma and their applicability for drug discovery.
Agarwal R; Agarwal P
Expert Opin Drug Discov; 2017 Mar; 12(3):261-270. PubMed ID: 28075618
[TBL] [Abstract][Full Text] [Related]
5. The use of cyclodialysis to limit exposure to elevated intraocular pressure in rat glaucoma models.
Johnson EC; Cepurna WO; Jia L; Morrison JC
Exp Eye Res; 2006 Jul; 83(1):51-60. PubMed ID: 16530758
[TBL] [Abstract][Full Text] [Related]
6. Inducible rodent models of glaucoma.
Pang IH; Clark AF
Prog Retin Eye Res; 2020 Mar; 75():100799. PubMed ID: 31557521
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
Ahmed FA; Hegazy K; Chaudhary P; Sharma SC
Brain Res; 2001 Sep; 913(2):133-9. PubMed ID: 11549376
[TBL] [Abstract][Full Text] [Related]
8. Radiation pretreatment does not protect the rat optic nerve from elevated intraocular pressure-induced injury.
Johnson EC; Cepurna WO; Choi D; Choe TE; Morrison JC
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):412-9. PubMed ID: 25525172
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of a dual ET
Kodati B; McGrady NR; Jefferies HB; Stankowska DL; Krishnamoorthy RR
Mol Vis; 2022; 28():165-177. PubMed ID: 36274816
[TBL] [Abstract][Full Text] [Related]
10. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.
Lambiase A; Aloe L; Centofanti M; Parisi V; Báo SN; Mantelli F; Colafrancesco V; Manni GL; Bucci MG; Bonini S; Levi-Montalcini R
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13469-74. PubMed ID: 19805021
[TBL] [Abstract][Full Text] [Related]
11. Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death.
Urcola JH; Hernández M; Vecino E
Exp Eye Res; 2006 Aug; 83(2):429-37. PubMed ID: 16682027
[TBL] [Abstract][Full Text] [Related]
12. Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model.
Danias J; Shen F; Kavalarakis M; Chen B; Goldblum D; Lee K; Zamora MF; Su Y; Brodie SE; Podos SM; Mittag T
Exp Eye Res; 2006 Feb; 82(2):219-28. PubMed ID: 16109406
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
14. A mouse model of elevated intraocular pressure: retina and optic nerve findings.
Gross RL; Ji J; Chang P; Pennesi ME; Yang Z; Zhang J; Wu SM
Trans Am Ophthalmol Soc; 2003; 101():163-9; discussion 169-71. PubMed ID: 14971574
[TBL] [Abstract][Full Text] [Related]
15. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma.
Naskar R; Wissing M; Thanos S
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2962-8. PubMed ID: 12202516
[TBL] [Abstract][Full Text] [Related]
16. Rat chronic glaucoma model induced by intracameral injection of microbeads suspended in sodium sulfate-sodium hyaluronate.
Matsumoto Y; Kanamori A; Nakamura M; Negi A
Jpn J Ophthalmol; 2014 May; 58(3):290-7. PubMed ID: 24610540
[TBL] [Abstract][Full Text] [Related]
17. Intracameral injection of a chemically cross-linked hydrogel to study chronic neurodegeneration in glaucoma.
Chan KC; Yu Y; Ng SH; Mak HK; Yip YWY; van der Merwe Y; Ren T; Yung JSY; Biswas S; Cao X; Chau Y; Leung CKS
Acta Biomater; 2019 Aug; 94():219-231. PubMed ID: 31176841
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma.
Shen C; Chen L; Jiang L; Lai TY
Neurosci Lett; 2015 Jul; 600():132-6. PubMed ID: 26050640
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
[TBL] [Abstract][Full Text] [Related]
20. Heterozygous Meg2 Ablation Causes Intraocular Pressure Elevation and Progressive Glaucomatous Neurodegeneration.
Reinhard J; Wiemann S; Joachim SC; Palmhof M; Woestmann J; Denecke B; Wang Y; Downey GP; Faissner A
Mol Neurobiol; 2019 Jun; 56(6):4322-4345. PubMed ID: 30315478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
